GERDEMANN ULRIKE ET AL: "Cytotoxic T lymphocytes simultaneously targeting multiple tumor-associated antigens to treat EBV negative lymphoma", MOLECULAR THERAPY, NATURE PUBLISHING GROUP, GB, vol. 19, no. 12, 1 December 2011 (2011-12-01), pages 2258-2268, XP008154173, ISSN: 1525-0024, DOI: 10.1038/MT.2011.167 (B1)

JAMES S. TESTA ET AL: "MHC Class I-Presented T Cell Epitopes Identified by Immunoproteomics Analysis Are Targets for a Cross Reactive Influenza-Specific T Cell Response", PLOS ONE, vol. 7, no. 11, 7 November 2012 (2012-11-07), page e48484, XP055454527, DOI: 10.1371/journal.pone.0048484 (B1)

U. Gerdemann ET AL: "Multivirus-specific CTL for adoptive transefr using in vitro pepmix stimulation", Biol. Blood Marrow Transplant., 1 February 2011 (2011-02-01), page S216, XP055200620, Retrieved from the Internet: URL:http://www.bbmt.org/article/S1083-8791 %2810%2900763-9/abstract [retrieved on 2015-07-07] (B1)

WO-A1-2011/028531 (B1)

ULRIKE GERDEMANN ET AL: "Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections", MOLECULAR THERAPY, 17 July 2012 (2012-07-17), XP055034394, ISSN: 1525-0016, DOI: 10.1038/mt.2012.130 (B1)

ULRIKE GERDEMANN ET AL: "Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant", MOLECULAR THERAPY, vol. 21, no. 11, 20 June 2013 (2013-06-20) , pages 2113-2121, XP055200632, ISSN: 1525-0016, DOI: 10.1038/mt.2013.151 (B1)

ULRIKE GERDEMANN ET AL: "Nucleofection of DCs to Generate Multivirus-specific T Cells for Prevention or Treatment of Viral Infections in the Immunocompromised Host", MOLECULAR THERAPY, vol. 17, no. 9, 1 September 2009 (2009-09-01), pages 1616-1625, XP055050633, ISSN: 1525-0016, DOI: 10.1038/mt.2009.140 (B1)